Show simple item record

dc.contributor.authorAhmad, Shama
dc.contributor.authorAhmad, Aftab
dc.contributor.authorHendry-Hofer, Tara B.
dc.contributor.authorLoader, Joan E.
dc.contributor.authorClaycomb, William C.
dc.contributor.authorMozziconacci, Olivier
dc.contributor.authorSchoneich, Christian
dc.contributor.authorReisdorph, Nichole
dc.contributor.authorPowell, Roger L.
dc.contributor.authorChandler, Joshua D.
dc.contributor.authorDay, Brian J.
dc.contributor.authorVeress, Livia A.
dc.contributor.authorWhite, Carl W.
dc.date.accessioned2016-12-16T18:17:41Z
dc.date.available2016-12-16T18:17:41Z
dc.date.issued2015-04
dc.identifier.citationAhmad, S., Ahmad, A., Hendry-Hofer, T. B., Loader, J. E., Claycomb, W. C., Mozziconacci, O., … White, C. W. (2015). Sarcoendoplasmic Reticulum Ca 2+ ATPase. A Critical Target in Chlorine Inhalation–Induced Cardiotoxicity . Am J Respir Cell Mol Biol, 52(4), 492–502. doi:10.1165/rcmb.2014-0005ocen_US
dc.identifier.urihttp://hdl.handle.net/1808/22251
dc.description.abstractAutopsy specimens from human victims or experimental animals that die due to acute chlorine gas exposure present features of cardiovascular pathology. We demonstrate acute chlorine inhalation–induced reduction in heart rate and oxygen saturation in rats. Chlorine inhalation elevated chlorine reactants, such as chlorotyrosine and chloramine, in blood plasma. Using heart tissue and primary cardiomyocytes, we demonstrated that acute high-concentration chlorine exposure in vivo (500 ppm for 30 min) caused decreased total ATP content and loss of sarcoendoplasmic reticulum calcium ATPase (SERCA) activity. Loss of SERCA activity was attributed to chlorination of tyrosine residues and oxidation of an important cysteine residue, cysteine-674, in SERCA, as demonstrated by immunoblots and mass spectrometry. Using cardiomyocytes, we found that chlorine-induced cell death and damage to SERCA could be decreased by thiocyanate, an important biological antioxidant, and by genetic SERCA2 overexpression. We also investigated a U.S. Food and Drug Administration–approved drug, ranolazine, used in treatment of cardiac diseases, and previously shown to stabilize SERCA in animal models of ischemia–reperfusion. Pretreatment with ranolazine or istaroxime, another SERCA activator, prevented chlorine-induced cardiomyocyte death. Further investigation of responsible mechanisms showed that ranolazine- and istaroxime-treated cells preserved mitochondrial membrane potential and ATP after chlorine exposure. Thus, these studies demonstrate a novel critical target for chlorine in the heart and identify potentially useful therapies to mitigate toxicity of acute chlorine exposure.en_US
dc.description.sponsorshipThis work was supported by the CounterACT Program, National Institutes of Health, Office of the Director, and the National Institute of Environmental Health Sciences grant U54 ES015678 (C.W.W.), and by Children’s Hospital of Colorado/Colorado School of Mines Pilot Award G0100394 and a Children’s Hospital of Colorado Research Institute’s Pilot Award (S.A.).en_US
dc.publisherAmerican Thoracic Societyen_US
dc.rightsCopyright © 2015 by the American Thoracic Societyen_US
dc.subjectChlorineen_US
dc.subjectInhalationen_US
dc.subjectCardiacen_US
dc.subjectSarcoendoplasmic reticulum Ca2+ATPaseen_US
dc.subjectRanolazineen_US
dc.titleSarcoendoplasmic Reticulum Ca2+ ATPase. A Critical Target in Chlorine Inhalation–Induced Cardiotoxicityen_US
dc.typeArticleen_US
kusw.kuauthorMozziconacci, Olivier
kusw.kuauthorSchoneich, Christian
kusw.kudepartmentPharmaceutical Chemistryen_US
dc.identifier.doi10.1165/rcmb.2014-0005OCen_US
kusw.oaversionScholarly/refereed, publisher versionen_US
kusw.oapolicyThis item meets KU Open Access policy criteria.en_US
dc.rights.accessrightsopenAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record